CIK 0001725160
- Non-accelerated filer
- Smaller reporting company
Zentalis Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ZNTL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 823607803
- Phone
- +1 858-263-4333
- Business address
- 10275 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- Zentalis Pharmaceuticals, LLC, Zeno Pharma, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-24 | SUN ANTHONY Y President & CEO | Sale | −100 | $47.56 | $5K | 2,119,774 |
| 2020-11-23 | Epperly Melissa B, Chief Financial Officer | Sale | −2,783 | $46.51 | $129K | 294,746 |
| 2020-11-23 | Epperly Melissa B, Chief Financial Officer | Sale | −300 | $47.26 | $14K | 294,446 |
| 2020-11-23 | Bunker Kevin D. Chief Operating Officer | Gift | −101,045 | 1,076,937 | ||
| 2020-11-23 | Bunker Kevin D. Chief Operating Officer | Gift | +101,045 | 101,045 | ||
| 2020-11-23 | Bunker Kevin D. Chief Operating Officer | Sale | −3,961 | $46.28 | $183K | 97,084 |
| 2020-11-23 | Bunker Kevin D. Chief Operating Officer | Sale | −4,064 | $46.71 | $190K | 93,020 |
| 2020-11-23 | Bunker Kevin D. Chief Operating Officer | Sale | −400 | $47.55 | $19K | 92,620 |
| 2020-11-23 | SUN ANTHONY Y President & CEO | Sale | −13,696 | $46.45 | $636K | 2,132,872 |
| 2020-11-23 | SUN ANTHONY Y President & CEO | Sale | −1,712 | $47.19 | $81K | 2,131,160 |
| 2020-11-23 | Gallagher Cam Director | Sale | −8,835 | $46.44 | $410K | 628,096 |
| 2020-11-23 | Gallagher Cam Director | Sale | −1,165 | $47.30 | $55K | 626,931 |
| 2020-11-22 | SUN ANTHONY Y President & CEO | Gift | −213,600 | 1,804,005 | ||
| 2020-11-22 | SUN ANTHONY Y President & CEO | Gift | +213,600 | 213,600 | ||
| 2020-10-28 | Recurium Equity, LLC 10% owner | Other disposition | −4,147,940 | 14,990 | ||
| 2020-08-31 | Pinto Alexis Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +275,000 | 275,000 | ||
| 2020-07-01 | Blackwell Kimberly Director | Grant or award · Stock Option (Right to Buy) | +42,000 | 42,000 | ||
| 2020-04-07 | Johnson David Michael Director | Purchase | +4,000 | $18.00 | $72K | 114,648 |
| 2020-04-07 | Epperly Melissa B, Chief Financial Officer | Purchase | +20,000 | $18.00 | $360K | 297,529 |
| 2020-04-07 | Bunker Kevin D. Chief Operating Officer | Purchase | +350 | $18.00 | $6K | 1,177,982 |
Page 31 of 32 · 627 trades